|
The following information was reported to gore: on (b)(6) 2025, this patient underwent endovascular treatment for an abdominal aortic aneurysm using gore® excluder®aaa endoprostheses and gore® molding & occlusion balloon catheter as an accessory.After the aortic extender was deployed, the physician inflated the mob balloon inside.Subsequently, an angiography revealed retrograde dissection extending from the proximal end of the aortic extender to below the right renal artery.As the dissection was localized, the procedure was completed with blood pressure management and follow-up observation.The physician¿s comment: ¿the cause is believed to be an overly forceful touch-up.¿.
|
|
H6: a review of the manufacturing records for the device verified that the lot met all pre-release specifications.H6: code d12: according to the gore® molding & occlusion balloon catheter instructions for use, adverse events that may occur and / or require intervention or additional intraoperative procedure time include but are not limited to: trauma to the vessel wall, including spasm, dissection, perforation, or rupture.W.L.Gore & associates, inc.(gore) is submitting this report to comply with 21 c.F.R.Part 803, the medical device reporting regulation.This report is based upon information obtained by gore, which the company may have not been able to fully investigate or verify prior to the date the report was required by the fda.Blank fields present on this report include required fields and fields determined to be not applicable.Blank required fields indicate that the information was not provided, was deemed unavailable or was not applicable.This report does not constitute an admission or a conclusion by fda, gore, or its associates that the device, gore or its associates caused or contributed to the event described in the report.In particular, this report does not constitute a legal admission by anyone that the product described in this report has any defects or has malfunctioned, as defined from a legal standpoint.These words are included in the report and are fixed items for selection created by the fda, to categorize the type of event solely for the purpose of reporting pursuant to part 803.This statement should be included with any information or report disclosed to the public under the freedom of information act.
|